05-23-0500 Sigma-AldrichBradykinin - CAS 58-82-2 - Calbiochem
Induces the release of nitric oxide.
More>> Induces the release of nitric oxide. Less<<Sinónimos: RPPGFSPFR
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
58-82-2 | C₅₀H₇₃N₁₅O₁₁ |
Precios y disponibilidad
Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
---|---|---|---|---|---|---|
05-23-0500-1MG |
|
Frasco de vidrio | 1 mg |
|
— | |
05-23-0500-25MG |
|
Ampolla de plást. | 25 mg |
|
— | |
05-23-0500-5MG |
|
Ampolla de plást. | 5 mg |
|
— |
Product Information | |
---|---|
CAS number | 58-82-2 |
ATP Competitive | N |
Form | White to off-white lyophilized solid |
Formulation | Supplied as an acetate salt. |
Hill Formula | C₅₀H₇₃N₁₅O₁₁ |
Chemical formula | C₅₀H₇₃N₁₅O₁₁ |
Hygroscopic | Hygroscopic |
Reversible | N |
Sold on the basis of peptide content | Y |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Induces the release of nitric oxide |
Purity | ≥97% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Peptide Content | Y |
Peptide Sequence | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | EE1530000 |
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
05-23-0500-1MG | 04055977206982 |
05-23-0500-25MG | 04055977206999 |
05-23-0500-5MG | 04055977207002 |
Documentation
Licencias necesarias
Título |
---|
PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
Bradykinin - CAS 58-82-2 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Bradykinin - CAS 58-82-2 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
05-23-0500 |
Referencias bibliográficas
Visión general referencias |
---|
Mombouli, J.V., and Vanhoutte, P.M. 1995. Am. J. Hypertens. 8, 195. Zhu, P., et al. 1995. Cardiovasc. Res. 29, 658. Bedarida, G.V., et al. 1994. Horm. Metab. Res. 26, 109. Altiok, N., and Fredholm, B.B. 1993. Cell Signal. 5, 279. |